Long-Acting Cabotegravir and Rilpivirine: Real World Outcomes at 3 Years. ANRS CO3 AquiVIH-NA Cohort
CROI 2026 Feb 22-25 Denver
M. Hessamfar1,2, O. Leleux2, A. Peyrouny-Mazeau2, C. Krzyzanowsky1, J Paumier3, A Minot3, S Bouchet4, G. Le Moal5, H. Ferrand6, A. Desclaux7, E. Lazaro8, P. Duffau9, Y. Gérard10, C Tumiotto11,12, F. Bonnet1,2
